Phase 0 5 trials
Phase 0
NCT06208033 Jan → Oct 2024 non-small cell lung carcinoma Fujian Cancer Hospital
Unknown
No outcome recorded
Phase 0
NCT05459441 Jan 2022 → Jun 2023 glioma , metastatic malignant neoplasm in the brain Shanghai Pudong Hospital
Unknown
No outcome recorded
Phase 0
NCT04220892 Jul 2020 high grade astrocytic tumor Jose Carrillo
Withdrawn
No outcome recorded
Phase 0
NCT02568033 Oct 2013 → Oct 2017 non-small cell lung carcinoma The Cooper Health System
Unknown
No outcome recorded
Phase 0
NCT00424242 Jan 2007 → Jan 2010 cancer of unknown primary site , central nervous system neoplasm , leukemia , lymphoproliferative syndrome +5 Northwestern University
Completed
No outcome recorded
Phase 1 86 trials · 1 met primary
Phase 1
NCT06946927 Jun 2025 → Feb 2026 overdue non-small cell lung carcinoma Jemincare
Recruiting
No outcome recorded
Phase 1
NCT06917079 Mar 2025 → Aug 2027 expected colorectal cancer , non-small cell lung carcinoma , pancreatic ductal adenocarcinoma TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Recruiting
No outcome recorded
Phase 1
NCT06835569 Mar 2025 → May 2029 expected colorectal cancer , non-small cell lung carcinoma , pancreatic ductal adenocarcinoma Alterome Therapeutics, Inc.
Recruiting
No outcome recorded
Phase 1
NCT06621563 Dec 2024 → Mar 2026 overdue colorectal cancer , non-small cell lung carcinoma Hansoh BioMedical R&D Company
Recruiting
No outcome recorded
Phase 1
NCT06704724 Dec 2024 → May 2026 colorectal neoplasm , non-small cell lung carcinoma , pancreatic ductal adenocarcinoma Pfizer
Terminated
No outcome recorded
Stop: Business
Phase 1
NCT06663306 Dec 2024 → Dec 2027 expected neoplastic meningitis , non-small cell lung carcinoma Shanghai Chest Hospital
Recruiting
No outcome recorded
Phase 1
NCT06594874 Oct 2024 → Oct 2026 expected non-small cell lung carcinoma Jiangsu Hansoh Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 1
NCT06561685 Sep 2024 → Oct 2027 expected metastatic neoplasm , non-small cell lung carcinoma Eli Lilly and Company
Recruiting
No outcome recorded
Phase 1
NCT06333951 Sep 2024 → Oct 2026 expected non-small cell lung carcinoma Amgen
Active not recruiting
No outcome recorded
Phase 1
NCT06447662 Jun 2024 → Oct 2026 expected colorectal neoplasm , non-small cell lung carcinoma , pancreatic ductal adenocarcinoma Pfizer
Active not recruiting
No outcome recorded
Phase 1
NCT06431685 Apr 2024 → Mar 2025 overdue malignant leptomeningeal tumor , non-small cell lung carcinoma Sichuan University
Recruiting
No outcome recorded
Phase 1
NCT05911308 Apr → Oct 2024 non-small cell lung carcinoma UNC Lineberger Comprehensive Cancer Center
Terminated
No outcome recorded
Phase 1
NCT05504278 Sep 2022 → May 2025 overdue non-small cell lung carcinoma Innovent Biologics (Suzhou) Co. Ltd.
Recruiting
No outcome recorded
Phase 1
NCT05273814 Aug 2022 → Aug 2023 non-small cell lung carcinoma Tianjin Medical University Cancer Institute and Hospital
Unknown
No outcome recorded
Phase 1
NCT04452214 Sep 2020 → Jun 2023 head and neck squamous cell carcinoma , melanoma , non-small cell lung carcinoma , urothelial carcinoma Cantargia AB
Completed
No outcome recorded
Phase 1
NCT04173338 Jan 2020 → Mar 2022 malignant mesothelioma , non-small cell lung carcinoma , urothelial carcinoma Augusta University
Terminated
No outcome recorded
Phase 1
NCT04185883 Dec 2019 → Dec 2026 expected cancer Amgen
Active not recruiting
No outcome recorded
Phase 1
NCT04162015 Nov 2019 → Nov 2027 expected malignant pleural mesothelioma Memorial Sloan Kettering Cancer Center
Active not recruiting
No outcome recorded
Phase 1
NCT03955042 Sep 2019 → Jul 2022 chordoma Saint John's Cancer Institute
Completed
No outcome recorded
Phase 1
NCT04077463 Sep 2019 → Feb 2027 expected non-small cell lung carcinoma Janssen Research & Development, LLC
Active not recruiting
No outcome recorded
Phase 1
NCT03987867 Jun 2019 → Jun 2021 non-small cell lung carcinoma Tianjin Medical University Cancer Institute and Hospital
Unknown
No outcome recorded
Phase 1
NCT03626922 May 2019 → Oct 2021 colorectal cancer NSABP Foundation Inc
Unknown
No outcome recorded
Phase 1
NCT03790228 Mar 2019 → Oct 2020 non-small cell lung carcinoma Henan Cancer Hospital
Unknown
No outcome recorded
Phase 1
NCT03628521 Jul 2018 → Dec 2019 lung cancer Shanghai Chest Hospital
Unknown
No outcome recorded
Phase 1
NCT03228537 Jul 2018 → Oct 2022 overdue malignant biphasic mesothelioma , pleural epithelioid mesothelioma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT03380871 May 2018 → Oct 2019 non-small cell lung carcinoma BioNTech US Inc.
Completed
No outcome recorded
Phase 1
NCT03509012 May 2018 → Dec 2020 head and neck squamous cell carcinoma , non-small cell lung carcinoma , small cell lung carcinoma AstraZeneca
Completed
No outcome recorded
Phase 1
NCT03307785 Oct 2017 → Feb 2020 metastatic malignant neoplasm , non-small cell lung carcinoma Tesaro, Inc.
Completed
No outcome recorded
Phase 1
NCT03233139 Jun 2017 → Sep 2027 expected cancer Regeneron Pharmaceuticals
Active not recruiting
No outcome recorded
Phase 1
NCT03064854 May 2017 → Jul 2021 non-small cell lung carcinoma Novartis Pharmaceuticals
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT03101579 Mar 2017 → Sep 2018 malignant tumor of meninges The First Hospital of Jilin University
Completed
No outcome recorded
Phase 1
NCT02922764 Nov 2016 → Jan 2025 endometrial cancer , non-small cell lung carcinoma Inspirna, Inc.
Completed
No outcome recorded
Phase 1
NCT02937116 Oct 2016 → Sep 2020 —
Innovent Biologics (Suzhou) Co. Ltd.
Completed
No outcome recorded
Phase 1
NCT02838745 Sep 2016 → Sep 2019 mesothelioma Baylor College of Medicine
Terminated
No outcome recorded
Phase 1
NCT02862457 Aug 2016 → Nov 2020 non-small cell lung carcinoma Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT02639091 Feb 2016 → May 2018 —
Bayer
Completed
No outcome recorded
Phase 1
NCT02639767 Dec 2015 → Dec 2016 malignant pleural mesothelioma Memorial Sloan Kettering Cancer Center
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 1
NCT02603003 Jun 2015 → Sep 2019 non-small cell lung carcinoma Shanghai University of Traditional Chinese Medicine
Completed
No outcome recorded
Phase 1
NCT02383212 Feb 2015 → Nov 2019 cancer Regeneron Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT01675765 Sep 2014 → Sep 2018 malignant pleural mesothelioma Aduro Biotech, Inc.
Completed
No outcome recorded
Phase 1
NCT02079636 Mar 2014 → May 2018 non-small cell lung carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT01784640 Jan 2014 → Oct 2018 non-small cell lung carcinoma , squamous cell lung carcinoma Jonsson Comprehensive Cancer Center
Completed
No outcome recorded
Phase 1
NCT02921984 Sep 2013 → Dec 2016 head and neck cancer , tumor of salivary gland Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Completed
No outcome recorded
Phase 1
NCT01723800 Jul 2013 → Sep 2016 non-small cell lung carcinoma City of Hope Medical Center
Completed
No outcome recorded
Phase 1
NCT01840579 Apr 2013 → Feb 2020 non-small cell lung carcinoma , small cell lung carcinoma Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT01809210 Apr 2013 → Jan 2016 non-small cell lung carcinoma AstraZeneca
Completed
No outcome recorded
Phase 1
NCT01664754 Sep 2012 → Jan 2019 non-small cell lung carcinoma Jonsson Comprehensive Cancer Center
Completed
No outcome recorded
Phase 1
NCT01700400 Sep 2012 → Oct 2014 non-small cell lung carcinoma Cancer Research and Biostatistics Clinical Trials Consortium
Completed
No outcome recorded
Phase 1
NCT01633970 Jul 2012 → Feb 2020 cancer Genentech, Inc.
Completed
No outcome recorded
Phase 1
NCT01567384 May 2012 → Oct 2013 cancer Emory University
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 1
NCT01548144 Apr 2012 → Aug 2021 cancer of unknown primary site M.D. Anderson Cancer Center
Terminated
No outcome recorded
Phase 1
NCT01454102 Dec 2011 → Jul 2016 non-small cell lung carcinoma Bristol-Myers Squibb
Completed
No outcome recorded
Phase 1
NCT01450384 Oct 2011 → Jan 2015 cancer of unknown primary site Virginia Commonwealth University
Completed
No outcome recorded
Phase 1
NCT01531790 Sep 2011 → Dec 2012 non-small cell lung carcinoma Jiangsu Simcere Pharmaceutical Co., Ltd.
Completed
No outcome recorded
Phase 1
NCT01416961 Aug → Dec 2011 lung cancer Barbara Ann Karmanos Cancer Institute
Withdrawn
No outcome recorded
Phase 1
NCT01192165 Sep 2010 → Oct 2013 cancer GlaxoSmithKline
Completed
Met primary
Phase 1
NCT01187615 Aug 2010 → Jun 2012 small cell lung carcinoma Bayer
Terminated
No outcome recorded
Phase 1
NCT00907179 Jul 2009 → Jul 2015 non-small cell lung carcinoma University of Pittsburgh
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT00916630 Jan 2009 → Sep 2015 central nervous system non-hodgkin lymphoma Massachusetts General Hospital
Completed
No outcome recorded
Phase 1
NCT00732992 Aug 2008 → Nov 2009 cancer Pfizer
Completed
No outcome recorded
Phase 1
NCT00733031 Aug 2008 → Mar 2009 cancer AstraZeneca
Terminated
No outcome recorded
Phase 1
NCT01215916 Feb 2008 → Dec 2011 cancer Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT00701857 Feb 2008 → Apr 2014 esophageal cancer University of Arizona
Completed
No outcome recorded
Phase 1
NCT00619424 Nov 2007 → Sep 2009 non-small cell lung carcinoma GlaxoSmithKline
Completed
No outcome recorded
Phase 1
NCT00528281 Sep 2007 → May 2009 non-small cell lung carcinoma GlaxoSmithKline
Completed
No outcome recorded
Phase 1
NCT00702299 Sep 2007 → Jan 2012 fallopian tube cancer , ovarian cancer , peritoneum cancer University of Arizona
Completed
No outcome recorded
Phase 1
NCT00390000 Jan 2007 → Aug 2016 cancer of unknown primary site Mayo Clinic
Completed
No outcome recorded
Phase 1
NCT00434174 Dec 2006 → Dec 2010 non-small cell lung carcinoma Novartis Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT00369629 Aug 2006 → Jul 2012 lymphoma Northwestern University
Terminated
No outcome recorded
Stop: Business
Phase 1
NCT00320073 Aug 2006 → Oct 2008 cancer of unknown primary site UNC Lineberger Comprehensive Cancer Center
Completed
No outcome recorded
Phase 1
NCT00402766 Aug 2006 → Feb 2014 mesothelioma M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1
NCT00330044 Apr 2006 → Aug 2009 non-small cell lung carcinoma Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Completed
No outcome recorded
Phase 1
NCT00291707 Mar 2006 → Mar 2008 head and neck cancer University of Pittsburgh
Completed
No outcome recorded
Phase 1
NCT00315861 Mar 2006 → May 2008 cervical cancer , endometrial cancer , lung cancer , ovarian cancer SCRI Development Innovations, LLC
Completed
No outcome recorded
Phase 1
NCT00454649 Dec 2005 → Aug 2009 neoplasm Pfizer
Completed
No outcome recorded
Phase 1
NCT00310050 Oct 2005 → May 2008 malignant pancreatic neoplasm Wake Forest University Health Sciences
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT01172028 Sep 2005 → Jul 2014 breast cancer , esophageal cancer , gastric cancer , head and neck cancer +3 University of Arizona
Completed
No outcome recorded
Phase 1
NCT02182102 Sep 2005 → May 2010 non-small cell lung carcinoma Boehringer Ingelheim
Completed
No outcome recorded
Phase 1
NCT00507858 Sep 2005 → Sep 2011 head and neck cancer M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1
NCT00506051 Jul 2005 → May 2006 non-small cell lung carcinoma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 1
NCT00470405 May 2004 → May 2007 cancer , lymphoma Vanderbilt-Ingram Cancer Center
Completed
No outcome recorded
Phase 1
NCT00070473 Oct 2003 → Mar 2006 childhood malignant neoplasm Children's Oncology Group
Completed
No outcome recorded
Phase 1
NCT00003706 Apr 1998 → Jun 2002 cancer of unknown primary site The University of Texas Health Science Center at San Antonio
Completed
No outcome recorded
Phase 1
NCT00003711 Sep 1997 → Sep 2004 cancer of unknown primary site San Antonio Cancer Institute
Completed
No outcome recorded
Phase 1
NCT00034463 — cancer , metastatic neoplasm Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT01170871 — cancer University of Southern California
Withdrawn
No outcome recorded
Show 76 more trials Phase 1/2 62 trials
Phase 1/2
NCT07594626 Dec 2027 → Dec 2030 expected biliary tract cancer , carcinoma of esophagus , colon carcinoma , metastatic carcinoma Northwestern University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07354061 Mar 2026 → Mar 2028 expected non-small cell lung carcinoma Tang-Du Hospital
Recruiting
No outcome recorded
Phase 1/2
NCT07472647 Feb 2026 → Feb 2029 expected non-small cell lung carcinoma , small cell lung carcinoma Shanghai JMT-Bio Inc.
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07397338 Jan 2026 → May 2029 expected colorectal cancer , metastatic neoplasm , non-small cell lung carcinoma Revolution Medicines, Inc.
Recruiting
No outcome recorded
Phase 1/2
NCT06462092 Jan 2026 → Jan 2027 expected malignant leptomeningeal tumor Guangzhou Medical University
Recruiting
No outcome recorded
Phase 1/2
NCT06405230 Oct 2025 → Jul 2026 non-small cell lung carcinoma GlaxoSmithKline
Terminated
No outcome recorded
Phase 1/2
NCT07121374 Jul 2025 → Jun 2028 expected pleural epithelioid mesothelioma University Hospital, Antwerp
Recruiting
No outcome recorded
Phase 1/2
NCT07070440 Jul 2025 → Jun 2027 expected non-small cell lung carcinoma Dizal Pharmaceuticals
Recruiting
No outcome recorded
Phase 1/2
NCT06943820 May 2025 → Dec 2026 expected colorectal adenocarcinoma , head and neck squamous cell carcinoma , non-small cell lung carcinoma Akeso
Recruiting
No outcome recorded
Phase 1/2
NCT06809517 Mar 2025 → Mar 2026 overdue neoplastic meningitis Guangzhou Medical University
Recruiting
No outcome recorded
Phase 1/2
NCT06809530 Mar 2025 → Dec 2026 expected neoplastic meningitis Guangzhou Medical University
Active not recruiting
No outcome recorded
Phase 1/2
NCT06762080 Mar 2025 → Sep 2026 overdue neoplastic meningitis Guangzhou Medical University
Active not recruiting
No outcome recorded
Phase 1/2
NCT06772623 Mar 2025 → Nov 2027 expected non-small cell lung carcinoma AbbVie
Recruiting
No outcome recorded
Phase 1/2
NCT05932199 Jul 2024 → May 2028 expected mesothelioma Baylor College of Medicine
Recruiting
No outcome recorded
Phase 1/2
NCT06462222 Jun 2024 → Sep 2026 overdue neoplastic meningitis Guangzhou Medical University
Active not recruiting
No outcome recorded
Phase 1/2
NCT05904379 Jul 2023 → Jun 2026 overdue non-small cell lung carcinoma Akeso
Active not recruiting
No outcome recorded
Phase 1/2
NCT05501665 May 2023 → Feb 2026 overdue non-small cell lung carcinoma Vanderbilt-Ingram Cancer Center
Recruiting
No outcome recorded
Phase 1/2
NCT05794477 Apr 2023 → Jul 2025 neoplasm Shanghai Hengrui Pharmaceutical Co., Ltd.
Unknown
No outcome recorded
Phase 1/2
NCT05636267 Feb 2023 → Feb 2025 non-small cell lung carcinoma Akeso
Terminated
No outcome recorded
Stop: Business
Phase 1/2
NCT05664971 Feb 2023 → Oct 2025 lung cancer Shanghai Junshi Bioscience Co., Ltd.
Completed
No outcome recorded
Phase 1/2
NCT05410145 Aug 2022 → Apr 2027 expected acute myeloid leukemia, KRAS gene mutation D3 Bio (Wuxi) Co., Ltd
Recruiting
No outcome recorded
Phase 1/2
NCT05180799 Aug 2022 → Mar 2025 overdue melanoma , non-small cell lung carcinoma BioAtla, Inc.
Active not recruiting
No outcome recorded
Phase 1/2
NCT05315700 Mar 2022 → Sep 2026 overdue cancer ORIC Pharmaceuticals
Recruiting
No outcome recorded
Phase 1/2
NCT05289908 Feb 2022 → Mar 2023 malignant leptomeningeal tumor The First Hospital of Jilin University
Completed
No outcome recorded
Phase 1/2
NCT04956640 Jul 2021 → Apr 2027 expected biliary tract neoplasm , colorectal neoplasm , endometrium neoplasm , non-small cell lung carcinoma +2 Eli Lilly and Company
Active not recruiting
No outcome recorded
Phase 1/2
NCT04717375 Apr 2021 → Jul 2025 cancer Sanofi
Terminated
No outcome recorded
Stop: Business
Phase 1/2
NCT04165070 Dec 2019 → Feb 2032 expected non-small cell lung carcinoma Merck Sharp & Dohme LLC
Recruiting
No outcome recorded
Phase 1/2
NCT03840915 Apr 2019 → Jul 2022 non-small cell lung carcinoma EMD Serono Research & Development Institute, Inc.
Completed
No outcome recorded
Phase 1/2
NCT03562871 Aug 2018 → Feb 2021 non-small cell lung carcinoma IO Biotech
Completed
No outcome recorded
Phase 1/2
NCT03507244 Apr 2018 → Jan 2019 neoplastic meningitis The First Hospital of Jilin University
Completed
No outcome recorded
Phase 1/2
NCT03337698 Dec 2017 → Oct 2025 non-small cell lung carcinoma Hoffmann-La Roche
Terminated
No outcome recorded
Phase 1/2
NCT03201146 Jun 2017 → Jul 2020 non-small cell lung carcinoma West China Hospital
Unknown
No outcome recorded
Phase 1/2
NCT03085914 May 2017 → Jan 2019 cancer Incyte Corporation
Completed
No outcome recorded
Phase 1/2
NCT02879669 Jun 2016 → May 2020 —
Targovax Oy
Unknown
No outcome recorded
Phase 1/2
NCT02574078 Nov 2015 → Apr 2020 non-small cell lung carcinoma Bristol-Myers Squibb
Completed
Mixed
Phase 1/2
NCT02039674 Feb 2014 → Nov 2016 non-small cell lung carcinoma Merck Sharp & Dohme LLC
Completed
Mixed
Phase 1/2
NCT01982955 Dec 2013 → Dec 2017 non-small cell lung carcinoma Merck KGaA, Darmstadt, Germany
Completed
No outcome recorded
Phase 1/2
NCT01397305 Apr 2011 → Oct 2014 rectal cancer Isofol Medical AB
Completed
No outcome recorded
Phase 1/2
NCT00921310 Sep 2009 → Jan 2013 non-small cell lung carcinoma Washington University School of Medicine
Terminated
No outcome recorded
Stop: Business
Phase 1/2
NCT00573989 Mar 2008 → Mar 2017 head and neck cancer Wake Forest University Health Sciences
Terminated
No outcome recorded
Phase 1/2
NCT00923273 Feb 2008 → Mar 2013 non-small cell lung carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1/2
NCT00604461 Oct 2007 → Jan 2011 mesothelioma H. Lee Moffitt Cancer Center and Research Institute
Terminated
No outcome recorded
Stop: Enrollment
Phase 1/2
NCT00482014 May 2007 → Oct 2011 non-small cell lung carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00470548 Apr 2007 → Oct 2014 breast cancer , lung cancer University of California, Davis
Terminated
No outcome recorded
Phase 1/2
NCT00447421 Feb 2007 → May 2008 small cell lung carcinoma Eli Lilly and Company
Terminated
No outcome recorded
Phase 1/2
NCT00374868 Aug 2006 → Apr 2008 urothelial carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00351039 Jul 2006 → Sep 2008 non-small cell lung carcinoma H. Lee Moffitt Cancer Center and Research Institute
Terminated
No outcome recorded
Stop: Enrollment
Phase 1/2
NCT00684099 May 2006 → May 2009 non-small cell lung carcinoma Hellenic Oncology Research Group
Completed
No outcome recorded
Phase 1/2
NCT00529100 Dec 2005 → Aug 2010 non-small cell lung carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00251550 Oct 2005 → Aug 2006 malignant pleural mesothelioma Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00489359 Jul 2005 → Feb 2010 ovarian cancer , primary peritoneal carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00190671 Jun 2005 → Mar 2008 breast cancer Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00216203 May 2005 → Dec 2008 non-small cell lung carcinoma Nasser Hanna, M.D.
Completed
No outcome recorded
Phase 1/2
NCT00389805 Mar 2005 → Dec 2006 lung cancer University of California, Davis
Completed
No outcome recorded
Phase 1/2
NCT00387322 Mar 2005 → Oct 2007 lung cancer University of California, Davis
Completed
No outcome recorded
Phase 1/2
NCT00101842 Dec 2004 → Jul 2006 transitional cell carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00320515 Mar 2004 → Jul 2008 gastric neoplasm Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00059865 Jan 2004 → Feb 2007 bile duct cancer , gallbladder cancer Alliance for Clinical Trials in Oncology
Completed
No outcome recorded
Phase 1/2
NCT00071136 Dec 2003 → Aug 2006 lung neoplasm Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00166465 Aug 2003 → Jun 2006 colorectal cancer Mayo Clinic
Completed
No outcome recorded
Phase 1/2
NCT00097383 — breast cancer Eli Lilly and Company
Completed
No outcome recorded
Phase 1/2
NCT00034502 — colorectal cancer Eli Lilly and Company
Completed
No outcome recorded
Show 52 more trials Phase 2 422 trials · 9 met primary · 22 missed
Phase 2
NCT07229339 Jun 2027 → Jun 2029 expected non-small cell lung carcinoma Jonsson Comprehensive Cancer Center
Not yet recruiting
No outcome recorded
Phase 2
NCT07845916 Oct 2026 → Jun 2027 expected non-small cell lung carcinoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not yet recruiting
No outcome recorded
Phase 2
NCT07858253 Oct 2026 → Oct 2030 expected lung carcinoma Anusha Chidharla, MD
Not yet recruiting
No outcome recorded
Phase 2
NCT07807722 Sep 2026 → Mar 2028 expected non-small cell lung carcinoma Hubei Cancer Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07586202 Jul 2026 → Mar 2028 expected non-small cell lung carcinoma Janssen Research & Development, LLC
Recruiting
No outcome recorded
Phase 2
NCT07492680 Jul 2026 → Aug 2028 expected cancer Bristol-Myers Squibb
Recruiting
No outcome recorded
Phase 2
NCT07709585 Jul 2026 → Jul 2030 expected non-small cell lung carcinoma Guangzhou University of Traditional Chinese Medicine
Not yet recruiting
No outcome recorded
Phase 2
NCT07624487 Jun 2026 → Dec 2028 expected lung adenocarcinoma Taipei Medical University Hospital
Recruiting
No outcome recorded
Phase 2
NCT07661173 Jun 2026 → Mar 2029 expected non-small cell lung carcinoma Anhui Provincial Cancer Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07551414 May 2026 → May 2027 expected neoplastic meningitis , non-small cell lung carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
No outcome recorded
Show all 422 trials opens the full record — a long page Phase 2/3 7 trials · 1 met primary
Phase 2/3
NCT07005102 Aug 2025 → Nov 2036 expected non-small cell lung carcinoma AbbVie
Recruiting
No outcome recorded
Phase 2/3
NCT07131319 Apr 2025 → Oct 2028 expected non-small cell lung carcinoma Second Affiliated Hospital of Nanchang University
Recruiting
No outcome recorded
Phase 2/3
NCT05255302 May 2022 → May 2025 overdue non-small cell lung carcinoma French Cooperative Thoracic Intergroup
Recruiting
No outcome recorded
Phase 2/3
NCT05209256 Mar 2022 → Jan 2024 non-small cell lung carcinoma The First Affiliated Hospital of Henan University of Science and Technology
Unknown
No outcome recorded
Phase 2/3
NCT03380468 Jan 2018 → Jan 2024 lung neoplasm Fudan University
Unknown
No outcome recorded
Phase 2/3
NCT03178552 Sep 2017 → Jun 2027 expected non-small cell lung carcinoma Hoffmann-La Roche
Active not recruiting
Mixed
Phase 2/3
NCT00775385 Apr 2009 → Apr 2013 non-small cell lung carcinoma French Cooperative Thoracic Intergroup
Completed
Met primary
Phase 3 75 trials · 13 met primary · 16 missed
Phase 3
NCT07715396 Oct 2026 → Oct 2031 expected non-small cell lung carcinoma AIO-Studien-gGmbH
Not yet recruiting
No outcome recorded
Phase 3
NCT07526792 Jun 2026 → Jun 2029 expected urothelial carcinoma CSPC Megalith Biopharmaceutical Co.,Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT07554846 May 2026 → May 2030 expected —
Fudan University
Recruiting
No outcome recorded
Phase 3
NCT07154368 Sep 2025 → Oct 2027 expected non-small cell lung carcinoma Guangzhou JOYO Pharma Co., Ltd
Not yet recruiting
No outcome recorded
Phase 3
NCT06632327 Dec 2024 → Apr 2029 expected non-small cell lung carcinoma Alliance for Clinical Trials in Oncology
Active not recruiting
No outcome recorded
Phase 3
NCT06417814 Oct 2024 → Sep 2026 overdue non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 3
NCT06485557 Aug 2024 → Dec 2025 overdue non-small cell lung carcinoma Tang-Du Hospital
Not yet recruiting
No outcome recorded
Phase 3
NCT06096844 Jul 2024 → Apr 2039 expected non-small cell lung carcinoma National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 3
NCT06093503 May 2024 → Apr 2028 non-small cell lung carcinoma AbbVie
Withdrawn
No outcome recorded
Stop: Business
Phase 3
NCT06382116 May 2024 → May 2026 overdue non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 3
NCT06097728 Nov 2023 → Nov 2028 expected pleural mesothelioma AstraZeneca
Active not recruiting
No outcome recorded
Phase 3
NCT05754853 Apr 2023 → Oct 2025 overdue urothelial carcinoma Shanghai Miracogen Inc.
Recruiting
No outcome recorded
Phase 3
NCT05493501 Dec 2022 → Aug 2023 non-small cell lung carcinoma EQRx International, Inc.
Terminated
No outcome recorded
Phase 3
NCT05112965 Dec 2021 → Jun 2027 expected neoplasm Hoffmann-La Roche
Active not recruiting
No outcome recorded
Phase 3
NCT05055908 Oct 2021 → Jul 2025 overdue lung cancer Hunan Province Tumor Hospital
Recruiting
No outcome recorded
Phase 3
NCT05059522 Sep 2021 → Dec 2026 expected non-small cell lung carcinoma , ovarian cancer , urothelial carcinoma Pfizer
Active not recruiting
No outcome recorded
Phase 3
NCT04585490 Aug 2021 → Dec 2026 expected non-small cell lung carcinoma Stanford University
Recruiting
No outcome recorded
Phase 3
NCT04923906 Aug 2021 → Jun 2024 overdue non-small cell lung carcinoma Jiangsu Hansoh Pharmaceutical Co., Ltd.
Active not recruiting
Met primary
Phase 3
NCT04762459 Aug 2021 → May 2026 overdue non-small cell lung carcinoma Chinese Academy of Medical Sciences
Enrolling by invitation
No outcome recorded
Phase 3
NCT04695925 Mar 2021 → Nov 2025 overdue non-small cell lung carcinoma Li Zhang, MD
Active not recruiting
No outcome recorded
Phase 3
NCT04334759 Feb 2021 → Jun 2025 malignant pleural mesothelioma PrECOG, LLC.
Completed
No outcome recorded
Phase 3
NCT04500704 Oct 2020 → Dec 2021 non-small cell lung carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Unknown
No outcome recorded
Phase 3
NCT04500717 Oct 2020 → Oct 2022 non-small cell lung carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Unknown
Met primary
Phase 3
NCT04035486 Jul 2019 → Apr 2023 overdue non-small cell lung carcinoma AstraZeneca
Active not recruiting
Met primary
Phase 3
NCT03976323 Jun 2019 → Feb 2024 non-small cell lung carcinoma Merck Sharp & Dohme LLC
Completed
Missed primary
Phase 3
NCT03793179 Apr 2019 → Sep 2027 expected non-small cell lung carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 3
NCT03768063 Feb 2019 → Jul 2028 expected cancer Hoffmann-La Roche
Active not recruiting
No outcome recorded
Phase 3
NCT03381066 Apr 2018 → Dec 2022 —
Yonsei University
Unknown
No outcome recorded
Phase 3
NCT03257267 Sep 2017 → Mar 2021 squamous cell carcinoma Regeneron Pharmaceuticals
Completed
Met primary
Phase 3
NCT03215706 Aug 2017 → Aug 2019 non-small cell lung carcinoma Bristol-Myers Squibb
Completed
Met primary
Phase 3
NCT03193788 Jan 2017 → Dec 2019 transitional cell carcinoma , ureter cancer , urinary bladder cancer Asan Medical Center
Unknown
No outcome recorded
Phase 3
NCT02859077 Aug 2016 → Jul 2017 non-small cell lung carcinoma Shanghai Pulmonary Hospital, Shanghai, China
Unknown
No outcome recorded
Phase 3
NCT02886195 Jul 2016 → Jul 2019 —
Fujian Cancer Hospital
Unknown
No outcome recorded
Phase 3
NCT02795884 Jun 2016 → Nov 2020 non-small cell lung carcinoma Yonsei University
Withdrawn
No outcome recorded
Phase 3
NCT01951469 Jan 2016 → Jun 2022 metastatic malignant neoplasm in the brain , non-small cell lung carcinoma Sun Yat-sen University
Unknown
Met primary
Phase 3
NCT02477826 Aug 2015 → Oct 2024 non-small cell lung carcinoma Bristol-Myers Squibb
Completed
Mixed
Phase 3
NCT02607592 Aug 2015 → Jun 2022 non-small cell lung carcinoma Sun Yat-sen University
Unknown
No outcome recorded
Phase 3
NCT02264990 Sep 2014 → Nov 2019 non-small cell lung carcinoma AbbVie
Completed
Missed primary
Phase 3
NCT02151981 Aug 2014 → Apr 2016 —
AstraZeneca
Completed
Met primary
Phase 3
NCT02076477 Jan 2014 → Oct 2020 non-small cell lung carcinoma Sichuan Cancer Hospital and Research Institute
Unknown
No outcome recorded
Phase 3
NCT02004184 Dec 2013 → Mar 2018 non-small cell lung carcinoma Norwegian University of Science and Technology
Terminated
Missed primary
Stop: Enrollment
Phase 3
NCT02001168 Oct 2013 → Dec 2020 non-small cell lung carcinoma Xinjiang Medical University
Unknown
No outcome recorded
Phase 3
NCT01850303 May 2013 → Aug 2018 non-small cell lung carcinoma French Cooperative Thoracic Intergroup
Completed
Missed primary
Phase 3
NCT03061058 Apr 2013 → Dec 2018 chemotherapy-induced toxicity , gastric neoplasm The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Unknown
No outcome recorded
Phase 3
NCT01656551 Aug 2012 → Nov 2024 non-small cell lung carcinoma National Cancer Institute, Naples
Unknown
No outcome recorded
Phase 3
NCT03402048 Jul 2012 → Dec 2020 bronchogenic carcinoma , non-small cell lung carcinoma University of Turin, Italy
Unknown
No outcome recorded
Phase 3
NCT01631136 Jul 2012 → May 2017 non-small cell lung carcinoma French Cooperative Thoracic Intergroup
Completed
Missed primary
Phase 3
NCT01593293 Mar 2012 → Nov 2014 non-small cell lung carcinoma Asan Medical Center
Unknown
No outcome recorded
Phase 3
NCT01154140 Jan 2011 → Nov 2013 non-small cell lung carcinoma Pfizer
Completed
Met primary
Phase 3
NCT01107626 Oct 2010 → Jan 2019 lung cancer ECOG-ACRIN Cancer Research Group
Completed
Missed primary
Phase 3
NCT01017874 Nov 2009 → Apr 2013 non-small cell lung carcinoma Eli Lilly and Company
Completed
Missed primary
Phase 3
NCT01005680 Nov 2009 → Nov 2012 non-small cell lung carcinoma Eli Lilly and Company
Completed
Missed primary
Phase 3
NCT00948675 Sep 2009 → Jan 2013 non-small cell lung carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT00961415 Aug 2009 → May 2011 non-small cell lung carcinoma Hoffmann-La Roche
Completed
Met primary
Phase 3
NCT00863512 Mar 2009 → Nov 2011 lung cancer Alliance for Clinical Trials in Oncology
Terminated
No outcome recorded
Phase 3
NCT00762034 Dec 2008 → Apr 2012 non-small cell lung carcinoma Eli Lilly and Company
Completed
Missed primary
Phase 3
NCT00789373 Nov 2008 → Jun 2010 non-small cell lung carcinoma Eli Lilly and Company
Completed
Met primary
Phase 3
NCT00738881 Oct 2008 → Dec 2011 non-small cell lung carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Stop: Enrollment
Phase 3
NCT00686959 Sep 2008 → Oct 2014 non-small cell lung carcinoma Eli Lilly and Company
Completed
Missed primary
Phase 3
NCT01836575 Apr 2008 → Jan 2012 non-small cell lung carcinoma Brazilian National Cancer Institute
Completed
Met primary
Phase 3
NCT00989690 Feb 2008 → ? lung cancer San Raffaele Scientific Institute
Unknown
Met primary
Phase 3
NCT00520676 Oct 2007 → Jul 2010 non-small cell lung carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT00324805 Jul 2007 → Oct 2015 non-small cell lung carcinoma National Cancer Institute (NCI)
Completed
Missed primary
Phase 3
NCT00415194 Dec 2006 → Mar 2010 head and neck neoplasm Eli Lilly and Company
Completed
Missed primary
Phase 3
NCT00391274 Oct 2006 → Dec 2008 non-small cell lung carcinoma Eli Lilly and Company
Completed
Missed primary
Phase 3
NCT00363415 Aug 2006 → Jun 2008 small cell lung carcinoma Eli Lilly and Company
Completed
Missed primary
Phase 3
NCT00440414 Apr 2006 → Apr 2010 non-small cell lung carcinoma Hellenic Oncology Research Group
Completed
No outcome recorded
Phase 3
NCT00284778 Feb 2006 → Dec 2009 non-small cell lung carcinoma University Hospital, Limoges
Completed
No outcome recorded
Phase 3
NCT00102804 Mar 2005 → Aug 2007 non-small cell lung carcinoma Eli Lilly and Company
Completed
Met primary
Phase 3
NCT00095199 Jan 2005 → Jul 2011 non-small cell lung carcinoma Eli Lilly and Company
Completed
Missed primary
Phase 3
NCT00087711 Jul 2004 → Jan 2007 non-small cell lung carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT00078260 Dec 2003 → Oct 2006 non-small cell lung carcinoma Eli Lilly and Company
Completed
Missed primary
Phase 3
NCT00190762 Oct 2001 → Nov 2005 mesothelioma Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT00005636 Nov 1999 → Nov 2000 malignant mesothelioma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 3
NCT00035035 — metastatic neoplasm , pancreatic neoplasm Eli Lilly and Company
Completed
No outcome recorded
Show 65 more trials Phase 4 17 trials · 1 met primary · 1 missed
Phase 4
NCT07279935 May 2026 → May 2030 expected non-small cell lung carcinoma AstraZeneca
Recruiting
No outcome recorded
Phase 4
NCT07092202 Apr 2025 → May 2027 expected malignant leptomeningeal tumor , non-small cell lung carcinoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Recruiting
No outcome recorded
Phase 4
NCT06357598 Jan → Dec 2024 non-small cell lung carcinoma The Affiliated Hospital of Qingdao University
Unknown
No outcome recorded
Phase 4
NCT06230055 Jan 2024 → Jan 2026 overdue Her2-receptor negative breast cancer , malignant leptomeningeal tumor Fudan University
Recruiting
No outcome recorded
Phase 4
NCT03656549 Feb 2019 → Dec 2023 mesothelioma , non-small cell lung carcinoma Radboud University Medical Center
Completed
No outcome recorded
Phase 4
NCT03655821 Feb 2019 → May 2021 mesothelioma , non-small cell lung carcinoma Radboud University Medical Center
Terminated
Missed primary
Phase 4
NCT03655834 Feb 2019 → Sep 2020 mesothelioma , non-small cell lung carcinoma Radboud University Medical Center
Completed
No outcome recorded
Phase 4
NCT03792503 Feb 2019 → Feb 2020 non-small cell lung carcinoma Xinqiao Hospital of Chongqing
Withdrawn
No outcome recorded
Phase 4
NCT03768037 Nov 2018 → Nov 2019 non-small cell lung carcinoma Guangdong Association of Clinical Trials
Unknown
No outcome recorded
Phase 4
NCT03460678 Feb → Nov 2018 non-small cell lung carcinoma Hikma Pharmaceuticals LLC
Terminated
No outcome recorded
Stop: Enrollment
Phase 4
NCT03607149 Apr 2017 → Feb 2020 non-small cell lung carcinoma Centre Georges Francois Leclerc
Completed
No outcome recorded
Phase 4
NCT02399566 May 2015 → Jan 2018 lung adenocarcinoma Hunan Province Tumor Hospital
Unknown
No outcome recorded
Phase 4
NCT02103257 Mar 2014 → Mar 2016 adenocarcinoma , non-small cell lung carcinoma Betta Pharmaceuticals Co., Ltd.
Unknown
No outcome recorded
Phase 4
NCT02031601 Jan 2014 → Dec 2016 non-small cell lung carcinoma Qilu Hospital of Shandong University
Unknown
Met primary
Phase 4
NCT01143974 Jun 2010 → Jun 2012 —
Chinese Academy of Medical Sciences
Completed
No outcome recorded
Phase 4
NCT01020786 Nov 2009 → Mar 2011 non-small cell lung carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 4
NCT00380718 Nov 2006 → Sep 2008 non-small cell lung carcinoma Eli Lilly and Company
Completed
No outcome recorded
Show 7 more trials Phase not applicable 15 trials
— NCT07542912 Jun 2026 → Jun 2029 expected —
Sun Yat-sen University
Not yet recruiting
No outcome recorded
— NCT07538193 May 2026 → May 2029 expected metastatic malignant neoplasm in the lymph nodes , non-small cell lung carcinoma Tang-Du Hospital
Not yet recruiting
No outcome recorded
— NCT07398599 Feb 2026 → Dec 2027 expected malignant leptomeningeal tumor , non-small cell lung carcinoma Second Affiliated Hospital of Nanchang University
Recruiting
No outcome recorded
— NCT06643000 Dec 2024 → Mar 2025 overdue malignant tumor of meninges , non-small cell lung carcinoma Henan Cancer Hospital
Recruiting
No outcome recorded
— NCT06576635 Dec 2024 → Sep 2026 overdue non-small cell lung carcinoma University of Illinois at Chicago
Recruiting
No outcome recorded
— NCT06304441 Apr 2024 → Jun 2026 overdue neoplastic meningitis Guangzhou Medical University
Recruiting
No outcome recorded
— NCT05305885 Aug 2022 → Oct 2023 neoplastic meningitis The First Hospital of Jilin University
Unknown
No outcome recorded
— NCT05527808 Aug 2022 → Jun 2025 lung adenocarcinoma Jun Liu
Unknown
No outcome recorded
— NCT04970043 Jul 2021 → Jul 2024 lung carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Unknown
No outcome recorded
— NCT03671538 Oct 2018 → Aug 2019 non-small cell lung carcinoma Lingyu Luo
Unknown
No outcome recorded
— NCT03566576 Jul → Sep 2018 non-small cell lung carcinoma Fujian Cancer Hospital
Unknown
No outcome recorded
— NCT03489616 Jan 2018 → Jul 2019 non-small cell lung carcinoma Shandong Cancer Hospital and Institute
Unknown
No outcome recorded
— NCT02145078 Jun 2014 → Jun 2015 non-small cell lung carcinoma Barbara Ann Karmanos Cancer Institute
Terminated
No outcome recorded
Stop: Enrollment
— NCT02148380 May → Dec 2014 non-small cell lung carcinoma Baohui Han
Completed
No outcome recorded
— NCT01860508 Feb 2013 → Feb 2014 non-small cell lung carcinoma Fudan University
Unknown
No outcome recorded
Show 5 more trials Phase not stated 1 trial
— NCT00040625 — mesothelioma Eli Lilly and Company
Approved for marketing
No outcome recorded
Comparator or background therapy 635 trials
Phase 1
NCT07699757 Background Jul 2026 → Apr 2029 expected non-small cell lung carcinoma , pancreatic ductal adenocarcinoma Haisco Pharmaceutical Group Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 1
NCT07608731 Background Jun 2026 → Apr 2029 expected diffuse large B-cell lymphoma of the central nervous system , large B-cell lymphoma Allison Winter
Not yet recruiting
No outcome recorded
Phase 1
NCT07381829 Background Oct 2025 → Dec 2026 expected —
HC Biopharma Inc.
Recruiting
No outcome recorded
Phase 1
NCT07004244 Background Jun 2025 → Dec 2027 expected cancer Sichuan University
Recruiting
No outcome recorded
Phase 1
NCT06969612 Background May 2025 → May 2027 expected non-small cell lung carcinoma Peking University Cancer Hospital & Institute
Recruiting
No outcome recorded
Show all 635 trials opens the full record — a long page